Turnstone Biologics Corp.
TSBX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $8,307 | $9,487 | $11,458 | $12,834 |
| - Cash | $16,688 | $21,847 | $28,926 | $24,133 |
| + Debt | $411 | $690 | $1,189 | $1,699 |
| Enterprise Value | -$7,970 | -$11,670 | -$16,279 | -$9,600 |
| Revenue | $0 | $0 | $2,018 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | $0 | -$301 | $1,009 | -$500 |
| % Margin | – | – | 50% | – |
| EBITDA | -$5,559 | -$11,503 | -$11,041 | -$17,877 |
| % Margin | – | – | -547.1% | – |
| Net Income | -$5,490 | -$11,806 | -$12,872 | -$17,032 |
| % Margin | – | – | -637.9% | – |
| EPS Diluted | -0.24 | -0.51 | -0.56 | -0.74 |
| % Growth | 52.9% | 8.9% | 24.3% | – |
| Operating Cash Flow | -$4,304 | -$7,091 | -$16,476 | -$17,485 |
| Capital Expenditures | $0 | $0 | $19 | $1 |
| Free Cash Flow | -$4,304 | -$7,091 | -$16,457 | -$17,484 |